Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Youn Kyung Chung, Jin Ju Kim, Min A. Hong, Kyu Ri Hwang, Soo Jin Chae, Sang Ho Yoon & Young Min Choi. (2021) Association Between Polycystic Ovary Syndrome and the Polymorphisms of Aryl Hydrocarbon Receptor Repressor, Glutathione-S-transferase T1, and Glutathione-S-transferase M1 Genes. Gynecological Endocrinology 37:6, pages 558-561.
Read now
Read now
Articles from other publishers (19)
William Atiomo, Fatma Alqutami, Sara Albasha & Mahmood Hachim. (2023) Deciphering the Role of Insulin-Like Growth Factor 1 in Endometrial Cancer in Patients With Polycystic Ovary Syndrome: Protocol for a Methodological Approach Using Cell Culture Experiments. JMIR Research Protocols 12, pages e48127.
Crossref
Crossref
Jing-Yu Luo, Shuai-Qi Shen, Hai-Jing Xu, Jin-Shu Yang & Wen-Ming Ma. (2023) The transcription factor masculinizer in sexual differentiation and achieved full functional sex reversal in prawn. iScience 26:7, pages 106968.
Crossref
Crossref
Anna Golara, Mateusz Kozłowski, Paweł Guzik, Sebastian Kwiatkowski & Aneta Cymbaluk-Płoska. (2023) The Role of Selenium and Manganese in the Formation, Diagnosis and Treatment of Cervical, Endometrial and Ovarian Cancer. International Journal of Molecular Sciences 24:13, pages 10887.
Crossref
Crossref
Shikha Rani & Piyush Chandna. (2022) Multiomics Analysis–Based Biomarkers in Diagnosis of Polycystic Ovary Syndrome. Reproductive Sciences 30:1, pages 1-27.
Crossref
Crossref
Ellen Marcus, Kaitlin Haines & Gregory M. Gressel. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
411
429
.
Verónica Yumiceba, Andrés López-Cortés, Andy Pérez-Villa, Iván Yumiseba, Santiago Guerrero, Jennyfer M. García-Cárdenas, Isaac Armendáriz-Castillo, Patricia Guevara-Ramírez, Paola E. Leone, Ana Karina Zambrano & César Paz-y-Miño. (2020) Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis. Frontiers in Endocrinology 11.
Crossref
Crossref
Elizabeth Carlin & Brandon Kramer. (2020) Hair, Hormones, and Haunting: Race as a Ghost Variable in Polycystic Ovary Syndrome. Science, Technology, & Human Values 45:5, pages 779-803.
Crossref
Crossref
Lucia Janacova, Jakub Faktor, Lenka Capkova, Vendula Paralova, Anna Pospisilova, Jan Podhorec, Holger Alexander Ebhardt, Roman Hrstka, Rudolf Nenutil, Ruedi Aebersold & Pavel Bouchal. (2020) SWATH-MS Analysis of FFPE Tissues Identifies Stathmin as a Potential Marker of Endometrial Cancer in Patients Exposed to Tamoxifen. Journal of Proteome Research 19:7, pages 2617-2630.
Crossref
Crossref
Sophie Möltgen, Eleonora Piumatti, Giuseppe Massafra, Sabine Metzger, Ulrich Jaehde & Ganna Kalayda. (2020) Cisplatin Protein Binding Partners and Their Relevance for Platinum Drug Sensitivity. Cells 9:6, pages 1322.
Crossref
Crossref
Jacopo Troisi, Claudia Cinque, Luigi Giugliano, Steven Symes, Sean Richards, David Adair, Pierpaolo Cavallo, Laura Sarno, Giovanni Scala, Maria Caiazza & Maurizio Guida. (2019) Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study. Journal of Ovarian Research 12:1.
Crossref
Crossref
Nina D. Kastueva, Tatyana D. Tsidaeva, Zalina F. Belikova & Liana V. Maysuradze. (2019) PATHOGENETIC ASPECTS OF METABOLIC SYNDROME IN WOMEN OF REPRODUCTIVE AGE (A LITERATURE REVIEW). Kuban Scientific Medical Bulletin 26:2, pages 162-172.
Crossref
Crossref
Mariona Jové, Irene Pradas, Alba Naudí, Susana Rovira-Llopis, Celia Bañuls, Milagros Rocha, Manuel Portero-Otin, Antonio Hernández-Mijares, Victor M. Victor & Reinald Pamplona. (2017) Lipidomics reveals altered biosynthetic pathways of glycerophospholipids and cell signaling as biomarkers of the polycystic ovary syndrome. Oncotarget 9:4, pages 4522-4536.
Crossref
Crossref
William Atiomo, Mohamad Nasir Shafiee, Caroline Chapman, Veronika M. Metzler, Jad Abouzeid, Ayşe Latif, Amy Chadwick, Sarah Kitson, Vanitha N. Sivalingam, Ian J. Stratford, Catrin S. Rutland, Jenny L. Persson, Niels Ødum, Pablo Fuentes-Utrilla, Jennie N. Jeyapalan, David M. Heery, Emma J. Crosbie & Nigel P. Mongan. (2017) Expression of NAD(P)H quinone dehydrogenase 1 (NQO1) is increased in the endometrium of women with endometrial cancer and women with polycystic ovary syndrome. Clinical Endocrinology 87:5, pages 557-565.
Crossref
Crossref
Mohamad Nasir Shafiee, Claire Seedhouse, Nigel Mongan, Caroline Chapman, Suha Deen, Jafaru Abu & William Atiomo. (2016) Up-regulation of genes involved in the insulin signalling pathway (IGF1, PTEN and IGFBP1) in the endometrium may link polycystic ovarian syndrome and endometrial cancer. Molecular and Cellular Endocrinology 424, pages 94-101.
Crossref
Crossref
Matthew M. Kwok & Paul Goodyear. (2015) Prognostic and Predictive Protein Biomarkers in Laryngeal Squamous Cell Carcinoma—A Systematic Review. International Journal of Otolaryngology and Head & Neck Surgery 04:03, pages 180-189.
Crossref
Crossref
N. Galazis, P. Athanasias & N. Pisal. (2014) Biochemical markers for endometriosis: a long way to go. Human Reproduction 29:10, pages 2352-2352.
Crossref
Crossref
Xiliang LuoQiao XuTim JamesJason J. Davis. (2014) Redox and Label-Free Array Detection of Protein Markers in Human Serum. Analytical Chemistry 86:11, pages 5553-5558.
Crossref
Crossref
Xinjie Zhao, Fang Xu, Bing Qi, Songli Hao, Yanjie Li, Yan Li, Lihong Zou, Caixia Lu, Guowang Xu & Lihui Hou. (2014) Serum Metabolomics Study of Polycystic Ovary Syndrome Based on Liquid Chromatography–Mass Spectrometry. Journal of Proteome Research 13:2, pages 1101-1111.
Crossref
Crossref
Mohamad N. Shafiee, Caroline Chapman, David Barrett, Jafaru Abu & William Atiomo. (2013) Reviewing the molecular mechanisms which increase endometrial cancer (EC) risk in women with polycystic ovarian syndrome (PCOS): Time for paradigm shift?. Gynecologic Oncology 131:2, pages 489-492.
Crossref
Crossref